These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17060421)

  • 21. Incorporating cost in power analysis for three-level cluster-randomized designs.
    Konstantopoulos S
    Eval Rev; 2009 Aug; 33(4):335-57. PubMed ID: 19509118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statistical significance, power and sample size - what does it all mean?
    Christley RM
    J Small Anim Pract; 2008 Jun; 49(6):263. PubMed ID: 18510495
    [No Abstract]   [Full Text] [Related]  

  • 23. Sample size determination for hierarchical longitudinal designs with differential attrition rates.
    Roy A; Bhaumik DK; Aryal S; Gibbons RD
    Biometrics; 2007 Sep; 63(3):699-707. PubMed ID: 17825003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of software for sample size determination.
    Dattalo P
    Eval Health Prof; 2009 Sep; 32(3):229-48. PubMed ID: 19696082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statistical significance, power and sample size--Part 2.
    Christley RM
    J Small Anim Pract; 2008 Jul; 49(7):321-2. PubMed ID: 18638056
    [No Abstract]   [Full Text] [Related]  

  • 26. A flexible strategy for testing subgroups and overall population.
    Alosh M; Huque MF
    Stat Med; 2009 Jan; 28(1):3-23. PubMed ID: 18985704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Power and sample size calculations for current status survival analysis.
    Williamson JM; Lin HM; Kim HY
    Stat Med; 2009 Jul; 28(15):1999-2011. PubMed ID: 19455509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statistical guidelines for clinical studies of human vision.
    Armstrong RA; Davies LN; Dunne MC; Gilmartin B
    Ophthalmic Physiol Opt; 2011 Mar; 31(2):123-36. PubMed ID: 21309799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sample size and power calculations for medical studies by simulation when closed form expressions are not available.
    Landau S; Stahl D
    Stat Methods Med Res; 2013 Jun; 22(3):324-45. PubMed ID: 22491174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statistical power in testing a hypothesis.
    Petrie A
    J Bone Joint Surg Br; 2010 Sep; 92(9):1192-4. PubMed ID: 20798433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
    Lui KJ; Chang KC
    Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A note on the power of Fisher's least significant difference procedure.
    Meier U
    Pharm Stat; 2006; 5(4):253-63. PubMed ID: 17128424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A planning tool for two-phase case-control studies.
    Schill W; Wild P; Pigeot I
    Comput Methods Programs Biomed; 2007 Nov; 88(2):175-81. PubMed ID: 17869374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypothesis: the research page. Part 3: Power, sample size, and clinical significance.
    Godwin M
    Can Fam Physician; 2001 Jul; 47():1441-3, 1450-3. PubMed ID: 11494932
    [No Abstract]   [Full Text] [Related]  

  • 35. Sample size determination.
    Dell RB; Holleran S; Ramakrishnan R
    ILAR J; 2002; 43(4):207-13. PubMed ID: 12391396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sample size determination for matched-pair equivalence trials using rate ratio.
    Tang NS; Tang ML; Wang SF
    Biostatistics; 2007 Jul; 8(3):625-31. PubMed ID: 17071862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How I do it: sample size calculations.
    O'Hara J
    Clin Otolaryngol; 2008 Apr; 33(2):145-9. PubMed ID: 18429871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Power and sample size when multiple endpoints are considered.
    Senn S; Bretz F
    Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings.
    Bedard PL; Krzyzanowska MK; Pintilie M; Tannock IF
    J Clin Oncol; 2007 Aug; 25(23):3482-7. PubMed ID: 17687153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.